Healthtech Startups

Maker of explosion-proof industrial gas-detection hardware, including photoionization, electrochemical, catalytic, and infrared gas sensors, VOC detectors, audible/visual alarms, and a wearable safety watch with location and emergency calling. Devices communicate wirelessly and upload monitoring data to an IoT platform.

1 investor

Olfera develops biopharmaceutical treatments for neurological conditions that use the olfactory system as a non-invasive pathway to the brain, bypassing the blood-brain barrier. Its platform is used to discover, optimize, and deliver drugs, converting existing FDA-approved and candidate neurological drugs into easier-to-administer therapies.

1 investor

OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.

1 investor

Olympus develops and distributes medical devices and technologies for minimally invasive therapeutic and diagnostic procedures, serving healthcare providers globally.

1 investor

Olympus develops medical technologies and solutions for detecting and treating disease. The company serves healthcare systems, patients, and medical professionals globally.

1 investor

Oma Care provides a platform that compensates caregivers for caring for their loved ones, addressing the caregiver experience.

1 investor

1 investor

Omanta provides personalized scientific research support for complex disease cases, assigning PhD-level teams to build detailed molecular profiles from a patient's genomic, RNA, and protein data. It cross-references each patient's molecular profile against an internal reference cohort and biomedical literature to model therapeutic options and produce a research roadmap that informs the clinical team's decisions.</parameter> <parameter name="founders">[]

1 investor

Healing chronic wounds with omega-3 nutrition

1 investor

Datma provides a federated data collaboration platform connecting health systems and labs with pharmaceutical companies for secure access to real-world clinical and molecular data. The platform enables pharma teams to access complete, de-identified datasets while allowing health systems and labs to maintain data control and generate revenue.

1 investor

Omini builds handheld biosensor devices that carry out clinical-grade blood analyses in minutes at the point of care. The devices are designed for clinicians who need diagnostic results during a patient visit rather than waiting on samples sent to a centralized laboratory.

1 investor

Omni makes electric scooter attachments that connect to wheelchairs, letting wheelchair users travel on urban and off-road terrain; the company states 95% of wheelchairs are compatible with its devices. It sells hardware including a wheel/scooter product ("MyOmniWheel") along with fitting assistance and after-sales support, serving people with reduced mobility in France.

1 investor

Omni AI is an AI-powered practice management and revenue cycle management platform for specialty physician practices, using AI agents to automate front-end administrative work such as benefit verification and prior authorization. It integrates with a practice's EMR, practice management, and clearinghouse systems, including custom connections to local HMO plans, to reduce claim denials and improve collections.

1 investor

Omni Saúde offers an employer-sponsored medication benefit in Brazil, providing employees a monthly credit via an app to buy prescription medicines at any pharmacy in the country. Purchases require a medical prescription and are paid through the app using PIX, with coverage determined by the plan the employer contracts.

1 investor

OmniActive develops scientifically validated, nature-based ingredients for the nutraceutical and natural products industry. The company specializes in extracting and delivering innovative ingredient solutions sourced from spices and natural materials.

1 investor

OmniBio develops biologically-inspired AI models for autonomous robots and machines used in manufacturing, agriculture, and construction. The technology enables robots to learn and adapt in dynamic environments without traditional sensors or connectivity.

1 investor

OmniBuds develops ear-worn biosensing earbuds that continuously monitor cardiovascular and physiological signals through AI-powered analysis. The platform serves researchers, clinicians, and health-conscious individuals seeking accessible, unobtrusive insight into their body's cardiovascular responses during daily life.

1 investor

Omnicare is a German healthcare group focused on oncology, operating medical care centers (MVZ) with physicians and oncologists across multiple sites, clean-room laboratories, pharmaceutical wholesale, hygiene monitoring, and quality initiatives for pharmacies and oncology practices. It also runs psychosomatic clinics and provides software (eApo) and training for medical staff.

1 investor

Omnicell develops medication management and automation solutions for healthcare facilities, enabling autonomous pharmacy operations across various care settings.

1 investor

OmniCyte is a biotechnology company developing vaccines and cancer immunotherapies, including a SARS-CoV-2 vaccine program and immune-response engineering work conducted in collaboration with academic medical centers. Its research focuses on recombinant vaccine development and immuno-oncology approaches.

1 investor

OmniLife Health develops FlowHawk, a clinical workflow automation platform that helps care teams manage complex care pathways, with initial focus on organ transplant centers. The platform digitizes care conversations outside the EHR and facilitates communication and collaboration across hospital teams.

1 investor

Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae. The company works with pharmaceutical and research partners to advance vaccine candidates through preclinical and clinical development.

1 investor

Omniscience.bio builds Vivo, an agentic AI "control tower" that unifies data from clinical trial systems (EDC, CTMS, labs, safety, imaging, eCOA, IRT, documents) into a governed layer where teams ask plain-language questions, monitor risk, and take source-backed action. It serves cross-functional clinical development teams, sponsors, and CRO/FSP partners running active trials, in the clinical trial software and life sciences category.

1 investor

Omnivers is a clinical care platform that consolidates patient data and tools—including task management, billing dashboards, telehealth, and remote patient monitoring—into a single interface for healthcare facilities. It integrates with systems such as PointClickCare, Matrix, and Sigma to help caregivers manage visits, documentation, and revenue.

1 investor